Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: Comparison with conventional ductal adenocarcinomas

American Journal of Pathology

Volumn 157, Issue 3, 2000, Pages 755-761

  Iacobuzio Donahue, Christine A ^a   Klimstra, David S ^b   Adsay, N Volkan ^c   Wilentz, Robb E ^a   Argani, Pedram ^a   Sohn, Taylor A ^a   Yeo, Charles J ^a   Cameron, John L ^a   Kern, Scott E ^a   Hruban, Ralph H ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN DPC 4; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CARCINOMA IN SITU; CELL LABELING; CONTROLLED STUDY; GENE INACTIVATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034495006     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64589-0     Document Type: Article

References (36)

1. Four cases of "mucin producing" cancer of the pancreas on specific findings of the papilla of Vater
2. Intraductal papillary neoplasms of the pancreas: A clinicopathologic study of six patients
3. The mucus-hypersecreting tumor of the pancreas
4. Intraductal papillary tumors and mucinous cystic tumors of the pancreas: Clinicopathologic study of 38 cases
5. Pancreatic neoplasms with abundant mucus production: Emphasis on intraductal papillary-mucinous tumors and mucinous cystic tumors
6. Diffuse intraductal papillary adenocarcinoma of the pancreas
7. Intraductal papillary-mucinous tumors of the pancreas: Clinicopathologic features, outcome and nomenclature
8. Intraductal papillary mucinous neoplasms of the pancreas associated with so-called "mucinous ductal ectasia." Histochemical and immunohistochemical analysis of 29 cases
9. The "duct-ectatic" variant of mucinous cystic neoplasm of the pancreas: Clinical and radiologic studies of seven cases
10. Characteristics and treatment of mucin-producing tumor of the pancreas
11. Intraductal neoplasms of the pancreas
12. Intraductal papillary mucinous tumours of the pancreas: Clinical and therapeutic issues in 32 patients
13. A clinicopathologic and immunohistochemical study of 22 intraductal papillary mucinous neoplasms of the pancreas, with a review of the literature
14. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas
15. Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas
16. Dpc4 transcriptional activation and dysfunction in cancer cells
17. DPC4 (SMAD4) mediates transforming growth factor-beta 1 (TGF-beta1)induced growth inhibition and transcriptional response in breast tumour cells
18. Genomic sequencing of DPC4 in the analysis of familial pancreatic carcinoma
19. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
20. DPC4 gene in various tumor types
21. DPC4 gene mutation in colitis associated neoplasia
22. Mutations of the DPC4/Smad4 gene in biliary tract carcinoma
23. Somatic alterations of the DPC4 gene in human colorectal cancers in vivo
24. Immunohistochemistry labeling for Dpc4 mirrors genetic status in pancreatic and peripancreatic adenocarcinomas: A new marker of DPC4 inactivation
25. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: Evidence that DPC4 inactivation occurs late in neoplastic progression
26. Intraductal oncocytic papillary neoplasms of the pancreas
27. Homozygous deletion map at 18q21.1 in pancreatic cancer
28. Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas
29. K-ras gene mutation in intraductal neoplasms of the pancreas
30. K-ras mutation and p53 protein accumulation in intraductal mucin-hypersecreting neoplasms of the pancreas
31. Ras gene mutations in intraductal papillary neoplasms of the pancreas: Analysis in five cases
32. An immunohistochemical study of the c-erbB-2 oncogene product in intraductal mucin-hypersecreting neoplasms and in ductal cell carcinomas of the pancreas
33. TGFβ responsiveness in DPC4/SMAD4-null cancer cells
34. DPC4/SMAD4 gene alterations in human cancer, and their functional implications
35. Allelic loss in colorectal carcinoma